Katie Peng

Katie Peng

Director/Board Member at SCHOLAR ROCK HOLDING CORPORATION

Net worth: 2 M $ as of 31/05/2026

55 year
Health Technology
Consumer Services
Commercial Services

Profile

Ms. Katie Peng is an Independent Director at Scholar Rock Holding Corp., an Independent Director at Adicet Bio, Inc. and a Chief Commercial Officer at Denali Therapeutics, Inc. She is on the Board of Directors at Scholar Rock Holding Corp., Adicet Bio, Inc. and California Life Sciences Association.
Ms. Peng was previously employed as a General Manager by Roche Products Ltd. (Taiwan), a General Manager by Roche Singapore Pte Ltd., and a Senior Vice President & Head-OMNI Business Unit by Genentech, Inc. She received her undergraduate degree from the University of California, Berkeley and an MBA from Kelley School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/06/2026 39,747 ( 0.03% ) 2 M $ 31/05/2026
21/06/2026 368 ( 0% ) 3 426 $ 31/05/2026

Katie Peng active positions

CompaniesPositionStart
DENALI THERAPEUTICS INC. Corporate Officer/Principal 27/09/2021
ADICET BIO, INC. Director/Board Member 10/07/2023
SCHOLAR ROCK HOLDING CORPORATION Director/Board Member 15/02/2024
Director/Board Member -

Former positions of Katie Peng

CompaniesPositionEnd
Roche Products Ltd. (Taiwan)
Chief Executive Officer 01/03/2017
Chief Executive Officer 01/03/2015
Corporate Officer/Principal -
See the detail of Katie Peng's experience

Training of Katie Peng

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

16

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Consumer Services

Health Technology

Roche Products Ltd. (Taiwan)

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology